TBA


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 02 08 2018
accepted: 04 12 2018
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 18 9 2020
Statut: epublish

Résumé

Superantigens (SAgs) play a major role in the pathogenesis of Staphylococcus aureus and are associated with several diseases, including food poisoning, bacterial arthritis, and toxic shock syndrome. Monoclonal antibodies to these SAgs, primarily TSST-1, SEB and SEA have been shown to provide protection in animal studies and to reduce clinical severity in bacteremic patients. Here we quantify the pre-existing antibodies against SAgs in many human plasma and IVIG samples and demonstrate that in a major portion of the population these antibody titers are suboptimal and IVIG therapy only incrementally elevates the anti-SAg titers. Our in vitro neutralization studies show that a combination of antibodies against SEA, SEB,and TSST-1 can provide broad neutralization of staphylococcal SAgs. We report a single fusion protein (TBA

Identifiants

pubmed: 30824769
doi: 10.1038/s41598-019-39890-z
pii: 10.1038/s41598-019-39890-z
pmc: PMC6397225
doi:

Substances chimiques

Enterotoxins 0
Recombinant Fusion Proteins 0
Staphylococcal Toxoid 0
Superantigens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3279

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI111205
Pays : United States

Références

mBio. 2013 Aug 20;4(4):
pubmed: 23963178
Eur Cell Mater. 2015 Dec 02;30:315-26
pubmed: 26629971
Am J Health Syst Pharm. 2015 Jun 15;72(12):1013-9
pubmed: 26025992
Proc Natl Acad Sci U S A. 1996 May 28;93(11):5425-30
pubmed: 8643591
Pediatr Infect Dis J. 2016 Feb;35(2):e60-4
pubmed: 26535878
J Med Microbiol. 1989 Mar;28(3):163-72
pubmed: 2926789
J Infect Dis. 1993 May;167(5):997-1002
pubmed: 8486972
J Infect Dis. 2014 Jun 15;209(12):1955-62
pubmed: 24357631
J Clin Microbiol. 2005 Sep;43(9):4628-34
pubmed: 16145118
J Infect Dis. 2003 Sep 1;188(5):743-52
pubmed: 12934191
Vaccine. 1998 Nov;16(19):1857-64
pubmed: 9795392
Hum Vaccin Immunother. 2013 Sep;9(9):1865-76
pubmed: 23793522
Vaccine. 2016 Dec 7;34(50):6402-6407
pubmed: 27847174
J Infect Chemother. 2007 Dec;13(6):368-72
pubmed: 18095084
Toxins (Basel). 2018 Jun 19;10(6):
pubmed: 29921792
Int J Antimicrob Agents. 2009 Jul;34 Suppl 1:S15-9
pubmed: 19560669
Blut. 1981 Dec;43(6):367-71
pubmed: 7332785
Hum Immunol. 1996 Jan;45(1):42-5
pubmed: 8655359
Infect Immun. 2011 Aug;79(8):3141-8
pubmed: 21628519
Crit Rev Microbiol. 1990;17(4):251-72
pubmed: 2206394
Int J Infect Dis. 2004 Sep;8(5):292-8
pubmed: 15325598
J Infect Dis. 2013 Dec 15;208(12):2058-66
pubmed: 23922375
PLoS Biol. 2017 Jun 20;15(6):e2001930
pubmed: 28632753
PLoS One. 2015 Sep 14;10(9):e0137874
pubmed: 26367030
Immunity. 1995 Aug;3(2):187-96
pubmed: 7648392
Br J Haematol. 1995 Apr;89(4):698-703
pubmed: 7772505
Nat Immun. 1995 Apr;14(4):188-97
pubmed: 8696008
Clin Infect Dis. 2013 Jun;56(11):1554-61
pubmed: 23446627
Protein Eng Des Sel. 2013 Feb;26(2):133-42
pubmed: 23161916
Pediatr Infect Dis J. 2009 Mar;28(3):244-6
pubmed: 19165132
Vaccine. 2012 Jul 20;30(34):5099-109
pubmed: 22691432
J Clin Immunol. 1995 Nov;15(6 Suppl):4S-10S
pubmed: 8613491
Clin Microbiol Infect. 2014 May;20 Suppl 5:66-75
pubmed: 24476315
Clin Microbiol Rev. 2013 Jul;26(3):422-47
pubmed: 23824366
Infect Immun. 1993 Dec;61(12):5333-8
pubmed: 8225606
Pediatr Infect Dis J. 2004 May;23(5):429-35
pubmed: 15131466
Lancet Infect Dis. 2016 Sep;16(9):1036-1044
pubmed: 27296693
Nat Protoc. 2007;2(9):2212-21
pubmed: 17853878
J Exp Med. 1995 Sep 1;182(3):711-20
pubmed: 7650479
J Immunol. 2014 Sep 15;193(6):2919-30
pubmed: 25092888
Clin Infect Dis. 2017 Apr 1;64(7):877-885
pubmed: 28034881
J Infect Dis. 2017 Apr 15;215(8):1231-1239
pubmed: 28329242
Clin Vaccine Immunol. 2016 Dec 5;23(12):918-925
pubmed: 27707765
Hum Vaccin Immunother. 2013 Aug;9(8):1679-84
pubmed: 23732904
J Immunol. 2009 Sep 1;183(5):2946-56
pubmed: 19657087
Immunol Cell Biol. 2012 Aug;90(7):699-709
pubmed: 22041925
J Infect Dis. 2012 Sep 15;206(6):915-23
pubmed: 22807524
Immunity. 2001 Mar;14(3):331-44
pubmed: 11290341
JAMA. 2013 Apr 3;309(13):1368-78
pubmed: 23549582
Hum Vaccin Immunother. 2014;10(12):3513-6
pubmed: 25483690
Semin Respir Crit Care Med. 2005 Dec;26(6):643-9
pubmed: 16388433
Curr Infect Dis Rep. 2014 Dec;16(12):447
pubmed: 25388018
PLoS One. 2012;7(6):e38567
pubmed: 22701668
Trends Microbiol. 2000 Aug;8(8):369-75
pubmed: 10920396
J Immunol. 2018 Jan 15;200(2):669-680
pubmed: 29237775
J Allergy Clin Immunol. 2001 Oct;108(4 Suppl):S107-10
pubmed: 11586276
Pathogens. 2016 Mar 17;5(1):
pubmed: 26999219
Infect Immun. 1997 Oct;65(10):4216-21
pubmed: 9317029
Infect Immun. 2004 Jul;72(7):4061-71
pubmed: 15213151
J Infect Dis. 2017 Mar 1;215(5):824-829
pubmed: 28035011
Virulence. 2017 Aug 18;8(6):741-750
pubmed: 27715466
J Clin Invest. 1993 Feb;91(2):602-7
pubmed: 8432865
PLoS One. 2013 Jun 07;8(6):e65384
pubmed: 23762356
J Infect Dis. 1999 Oct;180(4):1365-9
pubmed: 10479174

Auteurs

Arundhathi Venkatasubramaniam (A)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Rajan P Adhikari (RP)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Thomas Kort (T)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Grant C Liao (GC)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Shawn Conley (S)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Laura Abaandou (L)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Shweta Kailasan (S)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Yoshikuni Onodera (Y)

Daiichi Sankyo, Tokyo, Japan.

Subramaniam Krishnan (S)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Didier M Djagbare (DM)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Frederick W Holtsberg (FW)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

Hatice Karauzum (H)

Integrated Biotherapeutics, Inc., Rockville, MD, USA.

M Javad Aman (MJ)

Integrated Biotherapeutics, Inc., Rockville, MD, USA. jaman@integratedbiotherapeutics.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH